Diana Bahu Logan

Diana Bahu Logan is a Senior Scientist at Nxera Pharma, specializing in GPCR Drug Discovery since August 2021. Previously, Diana held positions as a Research Scientist at AstraZeneca, focusing on cell biology and therapeutic antibody protein expression, and as a Research Scientist at Ossianix, where work involved the delivery of therapeutics across the blood-brain barrier. Diana's earlier experience includes serving as a Senior Scientist at BioSyntha Technology Ltd, where research encompassed biotransformation, metabolite identification, and molecular biology, along with various analytical skills such as HPLC and LCMS. Diana began their career as a Scientist at Novacta Biosystems Ltd, conducting research in similar biotransformation and molecular biology projects. Diana completed education at Aalborg University in Denmark.